✦ LIBER ✦

Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitors

✍ Scribed by Regina Rendas-Baum, Gene V Wallenstein, Tamas Koncz…

Book ID: 120705848
Publisher: BioMed Central
Year: 2011
Tongue: English
Weight: 886 KB
Volume: 13
Category: Article
ISSN: 1478-6354
DOI: 10.1186/ar3249

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adding low dose tacrolimus in rheumatoid

Adding low dose tacrolimus in rheumatoid arthritis patients with an inadequate response to tumor necrosis factor inhibitor therapies

✍ Taio Naniwa; Maiko Watanabe; Shogo Banno; Tomoyo Maeda 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 258 KB

The efficacy of biologic agents in patie

The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic review

✍ Moots, R. J.; Naisbett-Groet, B. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 190 KB

Longterm Safety and Efficacy of Abatacep

Longterm Safety and Efficacy of Abatacept Through 5 Years of Treatment in Patients with Rheumatoid Arthritis and an Inadequate Response to Tumor Necrosis Factor Inhibitor Therapy

✍ GENOVESE, M. C.; SCHIFF, M.; LUGGEN, M.; LE BARS, M.; ARANDA, R.; ELEGBE, A.; DO 📂 Article 📅 2012 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 504 KB

Rituximab inhibits structural joint dama

Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies

✍ Keystone, E. (author);Emery, P. (author);Peterfy, C. G. (author);Tak, P. P. (aut 📂 Article 📅 2008 🏛 BMJ Publishing Group 🌐 English ⚖ 395 KB

Rituximab inhibits structural joint dama

Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies

✍ Keystone, E. (author);Emery, P. (author);Peterfy, C. G. (author);Tak, P. P. (aut 📂 Article 📅 2008 🏛 BMJ Publishing Group 🌐 English ⚖ 395 KB

Rituximab inhibits structural joint dama

Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies

✍ Keystone, E. (author);Emery, P. (author);Peterfy, C. G. (author);Tak, P. P. (aut 📂 Article 📅 2008 🏛 BMJ Publishing Group 🌐 English ⚖ 395 KB